Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyson Karesh

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2012
US perspective on off-label use in pediatricsAlyson Karesh, Andrew E Mulberg
Current Opinion in Pediatrics|September 3, 2013
Off-label use of medicine in pediatrics: focus on gastrointestinal diseasesAlyson Karesh, Juli Tomaino, Andrew E Mulberg
JAMA Pediatrics|August 8, 2013
Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007Jeremiah D Momper, Yeruk Mulugeta, Dionna J Green, et al.
Journal of Clinical Pharmacology|June 13, 2014
Drug development for pediatric neurogenic bladder dysfunction: dosing, endpoints, and study designJeremiah D Momper, Alyson Karesh, Dionna J Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2017
Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site InspectionsJanice Kim, Harpreet Singh, Kassa Ayalew, et al.
JAMA Network Open|June 17, 2025
Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health CollaborationDonna R Rivera, Tracy L Cutler, Lisa McShane, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2012
US perspective on off-label use in pediatricsAlyson Karesh, Andrew E Mulberg
Current Opinion in Pediatrics|September 3, 2013
Off-label use of medicine in pediatrics: focus on gastrointestinal diseasesAlyson Karesh, Juli Tomaino, Andrew E Mulberg
JAMA Pediatrics|August 8, 2013
Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007Jeremiah D Momper, Yeruk Mulugeta, Dionna J Green, et al.
Journal of Clinical Pharmacology|June 13, 2014
Drug development for pediatric neurogenic bladder dysfunction: dosing, endpoints, and study designJeremiah D Momper, Alyson Karesh, Dionna J Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2017
Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site InspectionsJanice Kim, Harpreet Singh, Kassa Ayalew, et al.
JAMA Network Open|June 17, 2025
Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health CollaborationDonna R Rivera, Tracy L Cutler, Lisa McShane, et al.
Pageof 1